Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s interface version or release revision indicator was updated from v3.5.2 to v3.5.3. This represents a system display/update rather than a change to the clinical trial details.
    Difference
    0.0%
    Check dated 2026-04-24T22:41:23.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    MRD and PFS endpoints have been updated to IMWG 2025 terminology and subgroups, with added notes on next‑generation sequencing and longer follow-up. The study location count changed from 217 to 209 locations.
    Difference
    1%
    Check dated 2026-04-17T14:13:47.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed the disease keyword 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' from the page's topics section.
    Difference
    0.0%
    Check dated 2026-04-03T07:24:46.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This appears to be a minor update with no visible changes to study content or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-03-20T00:22:40.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added related topics for Multiple myeloma and MedlinePlus Genetics; updated the page revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:39:38.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Removed references to 'Multiple myeloma' and related topics (MedlinePlus Genetics) from the page. This reduces disease-specific context presented in the study record.
    Difference
    0.0%
    Check dated 2026-02-26T14:31:18.000Z thumbnail image

Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.